Ananda Developments Plc (AQSE:ANA) is raising £2.15 million through a funding round at 0.3p.
Ananda said it will use the money to manufacture MRX1 for CIPN and Endometriosis Phase II studies, execute a pharmacokinetic study for MRX1 in Australia and general working capital.
In addition, a retail offer through the Winterflood WRAP platform is underway to raise up to a further £100,000.